Active

Boehringer Ingelheim Animal Health Belgium SA

Switched

BE0445411231

Rechtspersoon Public limited company 2 establishments

Arnaud Fraiteurlaan 15/23, 1050 Elsene Groothandel in farmaceutische en medische artikelen

Active for

34 year, 11 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Revenue

€ 50.6 million

▲ 8% vs 2024

Profit

Healthy

€ 233,984

▼ 83% vs 2024

Debts

Normal

€ 18.8 million

▲ 13% vs 2024

Boehringer Ingelheim Animal Health Belgium SA from Elsene, company number BE0445411231, closed financial year 2025 with a result of € 233,984 after tax. For that financial year Boehringer Ingelheim Animal Health Belgium SA recorded revenue of € 50.6 million and equity of € 4.2 million. Compared with financial year 2024, the result moved from € 1.4 million to € 233,984. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What happened at Boehringer Ingelheim Animal Health Belgium SA?

What happened at Boehringer Ingelheim Animal Health Belgium SA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Stephan KRICK stepped down as director. NBB
  • Lukas HAUSCHILD stepped down as director. NBB
  • Carla RAMON stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 233,984 (▼ 83% vs 2024). Source: NBB ↗
  • Stephan KRICK became a director. NBB
  • Christoph TAUTPHAEUS stepped down as director. NBB
  • Lukas HAUSCHILD became a director. NBB
  • Larisa NURKANOVIC stepped down as director. NBB

In short

From € 408,454 profit in 2021 to € 233,984 profit in 2025.

Paid € 2 million in corporate taxes since 2021.

Best year ever: 2024, with € 1.4 million profit.

Paid out € 4.8 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Boehringer Ingelheim Animal Health Belgium SA? We notify you, reason included.

Follow Boehringer Ingelheim Animal Health Belgium SA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

BOEHRINGER INGELHEIM AH INTERNATIONAL GMBH 100%
ANASCO GMBH 0%
Boehringer Ingelheim Animal Health Belgium SA

The shares are held by BOEHRINGER INGELHEIM AH INTERNATIONAL GMBH (100%) and ANASCO GMBH (0%).

See the full network in the app

Directors

According to the 2025 annual accounts

Sebastian GUIJARRO

Director

Also active at: Boehringer Ingelheim SComm, BOEHRINGER INGELHEIM CENTRE SA

since 2024 · until 2025

Christoph TAUTPHAEUS

Director

since 2025 · until 2026

Carla RAMON

Director

Also active at: BOEHRINGER INGELHEIM CENTRE SA, Boehringer Ingelheim Veterinary Medicine Belgium NV

since 2025 · until 2029

Larisa NURKANOVIC

Director

since 2025 · until 2026

Luis Miguel VITORIA MAGRO CORREIA

Managing director

since 2023 · until 2025

Chiedza KAITANO

Director

since 2024 · until 2025

Lukas HAUSCHILD

Director

Also active at: Boehringer Ingelheim SComm, BOEHRINGER INGELHEIM CENTRE SA

since 2026 · until 2029

Stephan KRICK

Managing director

since 2026 · until 2029

Shareholders

BOEHRINGER INGELHEIM AH INTERNATIONAL GMBH

100%

ANASCO GMBH

0%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Arnaud Fraiteurlaan 15/23

1050 Elsene

2.316.846.186

Noorwegenstraat 4

9940 Evergem

Active since 1 August 2020

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 31 companies are registered at this address.

Laboratoires Titra

€ -7,222 gross margin · 2024

Boehringer Ingelheim SComm same network

€ 164.7 million revenue · 2025

BOEHRINGER INGELHEIM CENTRE SA same network

A.J.B. INTERIEUR

€ 26,086 gross margin · 2025

Krys Construct

€ 25,462 gross margin · 2024

+26 more

Details

Company number
0445.411.231
VAT number
BE 0445.411.231
Registered office
Arnaud Fraiteurlaan 15/23, 1050 Elsene
Names & denominations
Boehringer Ingelheim Animal Health Belgium SA
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
8 October 1991
Peppol
Active · Active since 30 Mar 2026
Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the enterprise number of Boehringer Ingelheim Animal Health Belgium SA?
The enterprise number of Boehringer Ingelheim Animal Health Belgium SA is BE0445411231.
What is the address of Boehringer Ingelheim Animal Health Belgium SA?
The registered office of Boehringer Ingelheim Animal Health Belgium SA is located at Arnaud Fraiteurlaan 15/23, 1050 Elsene.
When was Boehringer Ingelheim Animal Health Belgium SA founded?
Boehringer Ingelheim Animal Health Belgium SA was founded on 8 October 1991.
What is the main activity of Boehringer Ingelheim Animal Health Belgium SA?
The main activity of Boehringer Ingelheim Animal Health Belgium SA is "Groothandel in farmaceutische en medische artikelen" (NACE code 46460).
Does Boehringer Ingelheim Animal Health Belgium SA have a website?
No website is currently known for Boehringer Ingelheim Animal Health Belgium SA.
How much profit did Boehringer Ingelheim Animal Health Belgium SA make in 2025?
Boehringer Ingelheim Animal Health Belgium SA posted a profit after taxes of € 233,984 in financial year 2025.
What is the revenue of Boehringer Ingelheim Animal Health Belgium SA?
In its most recent annual accounts (2025), Boehringer Ingelheim Animal Health Belgium SA reported revenue of € 50,582,196.
How many employees does Boehringer Ingelheim Animal Health Belgium SA have?
According to the 2025 annual accounts, Boehringer Ingelheim Animal Health Belgium SA has 38.4 full-time equivalents (FTE).
Where can I find the annual accounts of Boehringer Ingelheim Animal Health Belgium SA?
Boehringer Ingelheim Animal Health Belgium SA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Boehringer Ingelheim Animal Health Belgium SA?
According to the 2025 annual accounts, the directors of Boehringer Ingelheim Animal Health Belgium SA are: Sebastian GUIJARRO, Christoph TAUTPHAEUS, Carla RAMON, Larisa NURKANOVIC, Luis Miguel VITORIA MAGRO CORREIA, Chiedza KAITANO, Lukas HAUSCHILD, Stephan KRICK.
Who owns Boehringer Ingelheim Animal Health Belgium SA?
The shares are held by BOEHRINGER INGELHEIM AH INTERNATIONAL GMBH (100%) and ANASCO GMBH (0%).
Who are the shareholders of Boehringer Ingelheim Animal Health Belgium SA?
According to the 2025 annual accounts, the shareholders of Boehringer Ingelheim Animal Health Belgium SA are: BOEHRINGER INGELHEIM AH INTERNATIONAL GMBH (100%), ANASCO GMBH (0%).